Hilton Boston Back Bay, 40 Dalton St, Boston, Massachusetts, 02115, United States
The 5th Inflammasome Therapeutics Summit returns to Boston, bringing together industry pioneers at a crucial juncture with anticipated clinical readouts and new collaborations. Beyond NLRP3, inflammasomes offer potential targets for inflammation treatment. Join like-minded individuals to tackle discovery science, biomarker challenges, disease targeting, and preclinical model development. This premier gathering of inflammasome experts aims to advance inhibitors and activators from pipeline to human efficacy, featuring industry leaders from NodThera, Novartis, Roche, and more. Engage in interactive discussions with over 100 inflammasome pioneers.
The 4th Annual CRISPR 2.0 Congress is a leading event in the cell and gene therapy field, focusing on the latest advancements in CRISPR technology for safer and more efficient gene editing therapeutics. With 30+ speakers, 17 data readouts, and 16 tech presentations, this summit offers in-depth insights into technology innovation and clinical translation. Pre-conference workshops, including intellectual property and CRISPR trials, provide additional learning opportunities. Industry experts from Editas Medicine, CRISPR Therapeutics, Beam Therapeutics, and partners like ThermoFisher Scientific will be present, making this a must-attend event for gene and cell therapy professionals.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our